[HTML][HTML] Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer

LA Emens, S Adams, A Cimino-Mathews… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Breast cancer has historically been a disease for which immunotherapy was largely
unavailable. Recently, the use of immune checkpoint inhibitors (ICIs) in combination with …

[HTML][HTML] Malignancy after lung transplantation

O Shtraichman, VN Ahya - Annals of Translational Medicine, 2020 - ncbi.nlm.nih.gov
Lung transplantation is an established therapeutic option for selected patients with
advanced lung diseases. As early outcomes after lung transplantation have improved …

Hrvatske smjernice za liječenje odraslih osoba s debljinom

D Štimac, S Klobučar Majanović, M Baretić… - Acta medica Croatica …, 2022 - hrcak.srce.hr
Sažetak Debljina ili pretilost je kronična metabolička bolest karakterizirana prekomjernim
nakupljanjem masnog tkiva u organizmu. Iako većinu ljudi zabrinjava uglavnom zbog …

CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis

B Zhao, X Song, H Guan - Life sciences, 2020 - Elsevier
Background Breast cancer is the most common cancer occurred in female around the world.
The occurrence percentage of breast cancer among female who was over 50 years old is> …

MiR-16-5p inhibits breast cancer by reducing AKT3 to restrain NF-κB pathway

L Ruan, X Qian - Bioscience reports, 2019 - portlandpress.com
Background: Breast cancer endangers the life of women and has become the major cause
of deaths among them. MiRNAs are found to exert a regulatory effect on the migration …

Effects of caffeic acid phenethyl ester (CAPE) on angiogenesis, apoptosis and oxidatıve stress ın various cancer cell lines

F Fırat, M Özgül, E Türköz Uluer… - Biotechnic & …, 2019 - Taylor & Francis
Cancer is a common cause of death worldwide. Approximately 80% of cancer patients use
complementary or alternative medicines for treatment. Caffeic acid phenethyl ester (CAPE) …

Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.

G Li, D Xu, J Sun, S Zhao… - Advances in Clinical & …, 2020 - search.ebscohost.com
Background. Breast cancer has the highest incidence and mortality among all cancers in
women. Paclitaxel (PTX) has a notable therapeutic effect on cancer in clinical practice …

Breast cancer and cardiovascular health

T López-Fernández, I Marco, MC Aznar… - European Heart …, 2024 - academic.oup.com
Modern cancer therapies greatly improve clinical outcomes for both early and advanced
breast cancer patients. However, these advances have raised concerns about potential …

Should living donor liver transplantation be an option when deceased donation is not?

SR Lieber, TD Schiano, R Rhodes - Journal of hepatology, 2018 - Elsevier
When a liver transplantation candidate is declined for listing to receive a deceased organ,
sometimes a loved one comes forward and offers to be a living donor. This raises the ethical …

Implications of cancer prior to and after heart transplantation

P Mudigonda, C Berardi, V Chetram, A Barac, R Cheng - Heart, 2022 - heart.bmj.com
Cancer and cardiovascular disease share many risk factors. Due to improved survival of
patients with cancer, the cohort of cancer survivors with heart failure referred for heart …